Company Filing History:

11 out of 1,858

Takeda Chemical Industries, Inc.

patents

2 out of 1,179

Takeda Pharmaceutical Company Limited

patents

1 out of 573

Tokyo Institute of Technology

patents

where one patent can have more than one assignee

Years Active: 1996-2009

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7498352 - TGF-β superfamily production/secretion promoter (2009-03-03),

2. 7462635 - Thiazole and oxazole VDAC regulator (2008-12-09),

3. 6613761 - Benzoxazepine compounds, their production and use (2003-09-02),

4. 6545009 - Retinoid-related receptor function regulating agent (2003-04-08),

5. 6235731 - Fused imidazopyridine derivatives as antihyperlipidemic agents (2001-05-22),

6. 6110909 - Benzoxazepine compounds, their production and use as lipid lowering (2000-08-29),

7. 5998433 - Condensed compounds, their production and use (1999-12-07),

8. 5929107 - Condensed heterocyclic compounds, their production and use (1999-07-27),

9. 5885979 - N-containing condensed heterocyclic compounds, their production, and (1999-03-23),

10. 5726306 - 4,1-benzoxazepin derivatives and their use (1998-03-10),

11. 5698691 - Condensed cyclic compounds and their use (1997-12-16),

12. 5677298 - Benzoxazepine-2-one compounds and their use (1997-10-14),

13. 5492929 - Condensed heterocyclic compounds useful for inhibiting acyl-CoA (1996-02-20),

Title: **Yasuo Sugiyama: Innovations in Biotechnology**

Introduction

Yasuo Sugiyama is a notable inventor based in Kawanishi, Japan, recognized for his significant contributions to the field of biotechnology. With an impressive portfolio of 13 patents, Sugiyama has focused on developing innovative solutions aimed at improving human health and addressing various medical conditions.

Latest Patents

Among his latest inventions, Sugiyama has developed a TGF-β superfamily production/secretion promoter. This invention includes a complex formula designed to serve as an agent for the prophylaxis or treatment of dysautonomia, bladder dysfunction, hearing impairment, and bone disease. Another notable patent is the Thiazole and oxazole VDAC regulator, which is designed to aid in the treatment of Down's syndrome and similar conditions. Both inventions highlight Sugiyama's commitment to harnessing advanced chemical compounds to foster medical advancements.

Career Highlights

Yasuo Sugiyama has worked with esteemed companies such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His experience in these prominent organizations has enabled him to cultivate his innovative ideas and contribute to significant research in pharmaceutical developments.

Collaborations

Throughout his career, Sugiyama has collaborated with talented colleagues like Ryuichi Tozawa and Hidefumi Yukimasa. These partnerships have played an essential role in expanding the scope of his projects and fostering an environment of creative scientific inquiry.

Conclusion

Yasuo Sugiyama's dedication to innovation and research has positioned him as a key figure in the biotechnology sector. His patents not only demonstrate his inventive prowess but also contribute to the ongoing quest for effective treatments for various health challenges. As he continues to develop groundbreaking ideas, Sugiyama reinforces the importance of research and innovation in improving quality of life through science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com